See more : OPUS GLOBAL Nyrt. (OPUS.BD) Income Statement Analysis – Financial Results
Complete financial analysis of Predictmedix Inc. (PMED.CN) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Predictmedix Inc., a leading company in the Medical – Devices industry within the Healthcare sector.
- OrderYOYO A/S (YOYO.CO) Income Statement Analysis – Financial Results
- Alligo AB (publ) (ALLIGO-B.ST) Income Statement Analysis – Financial Results
- Arrayit Corporation (ARYC) Income Statement Analysis – Financial Results
- Jervois Global Limited (JRVMF) Income Statement Analysis – Financial Results
- BrightSpire Capital, Inc. (BRSP) Income Statement Analysis – Financial Results
Predictmedix Inc. (PMED.CN)
About Predictmedix Inc.
Predictmedix Inc., an artificial intelligence (AI) company, develops AI powered technologies for general workplace health and safety, and health care industry. The company operates in two segments, Workplace Health and Safety, and Healthcare. It offers disease symptom screening solutions to identify persons who are more likely to test positive for infectious diseases and to undergo a definitive test, such as a rapid COVID test. The company also develops impairment detection screening scanners and mental health screening stations; and Mobile Wellbeing, a telemedicine remote patient monitoring platform. The company was formerly known as Cultivar Holdings Inc. and changed its name to Predictmedix Inc. in April 2020. Predictmedix Inc. is headquartered in Toronto, Canada.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | 0.00 | 35.02K | 134.82K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 167.63K | 8.40K | 50.00K | 3.51K | 1.67K | 14.82K |
| Gross Profit | -167.63K | 26.62K | 84.82K | -3.51K | -1.67K | -14.82K |
| Gross Profit Ratio | 0.00% | 76.01% | 62.91% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 82.60K | 72.89K | 26.30K | 73.73K | 42.18K |
| General & Administrative | 1.09M | 1.56M | 1.31M | 586.15K | 723.45K | 154.56K |
| Selling & Marketing | 389.35K | 294.06K | 508.61K | 221.67K | 0.00 | 18.76K |
| SG&A | 1.75M | 1.85M | 1.81M | 1.90M | 723.45K | 250.61K |
| Other Expenses | 0.00 | 0.00 | 79.29K | 3.51K | 19.48K | 0.00 |
| Operating Expenses | 1.82M | 2.09M | 1.97M | 1.93M | 816.66K | 297.30K |
| Cost & Expenses | 1.98M | 2.10M | 2.02M | 1.93M | 816.66K | 312.12K |
| Interest Income | 0.00 | 2.87K | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 9.02K | 2.87K | 0.00 | 0.00 | 4.17K | 0.00 |
| Depreciation & Amortization | 167.63K | 159.46K | 79.29K | 3.51K | 1.67K | 3.77K |
| EBITDA | -1.82M | -1.91M | -1.80M | -1.87M | -2.27M | -309.91K |
| EBITDA Ratio | 0.00% | -5,440.98% | -1,337.26% | 0.00% | 0.00% | 0.00% |
| Operating Income | -1.91M | -1.95M | -1.73M | -1.93M | -816.66K | -313.68K |
| Operating Income Ratio | 0.00% | -5,560.75% | -1,284.40% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | -80.75K | -2.87K | 0.00 | 0.00 | -1.46M | 1.56K |
| Income Before Tax | -1.99M | -2.07M | -1.88M | -1.93M | -2.31M | -312.12K |
| Income Before Tax Ratio | 0.00% | -5,904.50% | -1,396.07% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | -117.51K | -150.55K | -2.84K | -15.21K | -37.47K |
| Net Income | -1.99M | -2.07M | -1.88M | -1.93M | -2.30M | -274.65K |
| Net Income Ratio | 0.00% | -5,904.50% | -1,396.07% | 0.00% | 0.00% | 0.00% |
| EPS | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | 0.00 |
| EPS Diluted | -0.01 | -0.02 | -0.02 | -0.02 | -0.02 | 0.00 |
| Weighted Avg Shares Out | 142.93M | 114.17M | 107.93M | 101.20M | 97.82M | 57.37M |
| Weighted Avg Shares Out (Dil) | 142.93M | 114.17M | 107.93M | 101.20M | 97.82M | 57.37M |
Source: https://incomestatements.info
Category: Stock Reports